Making a breakthrough targeted therapeutic means steering your candidates through the drug development process. The development of a targeted therapeutic is complex, costly, and filled with challenges.
There are many assays available to enable you to identify, test, eliminate, and optimize thousands of targets and compounds in the hope of bringing a few to clinical trials.
“A Work in Progress: What It Takes to Develop Your Targeted Therapeutic” highlights, with example studies, the assays and stages to efficiently develop your targeted therapeutic, including:
View Pages
You can access your copy of "A Work in Progress: What It Takes to Develop Your Targeted Therapeutic" here.
When you complete this form, your information is collected by LICORbio (United States) and shared with LI-COR and its subsidiaries, LI-COR INC, LI-COR GmbH (Germany) and LI-COR Ltd (United Kingdom). LI-COR and its subsidiaries work closely together to provide scientific expertise and prompt responses to customers globally. Depending on your location, your information may also be shared with a distribution partner. For more details, view our Privacy Policy (www.licor.com/privacy) or contact privacy@licor.com.
